Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A3 pseudogene 11 (HNRNPA3P11)
- Target
- HNRNPA3P11
- Molecular classification
- Other (pseudogene; related through ancestry to RNA-binding protein family)
01
Overview
Heterogeneous nuclear ribonucleoprotein A3 pseudogene 11 (HNRNPA3P11) is a human pseudogene related to heterogeneous nuclear ribonucleoprotein A3 (HNRNPA3). Pseudogenes such as HNRNPA3P11 do not encode functional proteins due to accumulated mutations, but recent research indicates that some pseudogenes may have regulatory roles as competitive endogenous RNAs (ceRNAs), potentially influencing gene expression by interacting with microRNAs or RNA-binding proteins. HNRNPA3P11 does not encode an active RNA-binding protein and has not been established as a direct therapeutic target, biomarker, or as having well-characterized biological functions or disease associations. In oncology and transcriptomics, parental genes of such pseudogenes (e.g., HNRNPA3) have roles in RNA processing, cancer biology, and may serve as biomarkers, but HNRNPA3P11 itself currently lacks demonstrated clinical or molecular utility.
- Other names
- HNRNPA3P11heterogeneous nuclear ribonucleoprotein A3 pseudogene 11
02
Mechanism of action
Not applicable (pseudogene, not a drug target)
03
Biological functions
Competitive endogenous RNA (ceRNA) activity (potential to act as miRNA sponge)Regulation of parental gene expression through transcript interactionsNo direct protein-coding functions
04
Disease associations
Other (pseudogenes, including HNRNPA3-related pseudogenes, have emerging evidence for involvement as ceRNAs in cancer and gene regulation)No direct evidence for specific disease role of HNRNPA3P11
05
Safety considerations
None; pseudogenes are not direct therapeutic targets, so typical safety concerns are not documented
06
Biomarkers
None specific to HNRNPA3P11; parental gene HNRNPA3, but not the pseudogene, is explored as a cancer biomarker
Beyond the preview
Go deeper on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 11 (HNRNPA3P11).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 11 (HNRNPA3P11).